Earlier, the state government had extended the Covid curbs till May 31.
Infection tally at 16,83,866
We are engaged with Pfizer as they have indicated the availability of a certain volume of vaccines in the coming months, possibly in July, says NITI member
The announcement for extension of the curbs came three days before they were scheduled to come to an end
The comment comes amid accusations of delay in placing orders for vaccines
Covid cases in the national capital have been on a downswing in recent weeks
Compensation to states also on the agenda
The Central government on Thursday announced that Covid-19 vaccine trials on children in the country would begin soon.
"These myths are arising due to distorted statements, half-truths and blatant lies," NITI Aayog added in its statement.
India has so far administered 202,695,874 vaccine doses. That is 740.60 per cent of its total caseload, and 14.56 per cent of its population
Covaxin production by Bharat Biotech is being increased: Paul
The HC will continue hearing in the matter next week.
Govt says working with Pfizer for earliest import; multiple rounds of talks held with J&J, Moderna
HCL is investing over Rs 100 crore to ensure free vaccination services for employees and their families
Dominic Cummings gives a damning account of UK govt's Covid response, German scientists claim they can help prevent blood clots, and other pandemic-related news across the globe
More than 18.4 million crore Covid-19 vaccine doses are still available with states and UTs
The Telangana Government will undertake a special Covid-19 vaccination drive for all accredited journalists on May 28 and 29 across the state
Speculations are rife that some attempts were on within the ruling BJP to replace him
The B16172 variant is now dominant in the UK, and there have been fears that its sudden rise could derail Britain's exit from lockdown
Earlier, Anvisa denied permission to import Covaxin after its authorities found that the plant in which the jab is being made did not meet the Good Manufacturing Practice (GMP) requirements